Beta Drugs Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 12, 2026

Key Highlights

The Latest Trading Price of Beta Drugs Ltd is ₹ 1372 as of 12 May 14:39 . The P/E Ratio of Beta Drugs Ltd changed from 9.8 on March 2021 to 45.3 on March 2025 . This represents a CAGR of 35.82% over 5 yearsThe P/E Ratio of Solara Active Pharma Sciences Ltd changed from 22.6 on March 2021 to 3943 on March 2025 . This represents a CAGR of 180.78% over 5 years The Market Cap of Beta Drugs Ltd changed from ₹ 115.37 crore on March 2021 to ₹ 1923 crore on March 2025 . This represents a CAGR of 75.55% over 5 yearsThe Market Cap of Solara Active Pharma Sciences Ltd changed from ₹ 5009 crore on March 2021 to ₹ 2005 crore on March 2025 . This represents a CAGR of -16.73% over 5 years The revenue of Beta Drugs Ltd for the Dec '25 is ₹ 89.58 crore as compare to the Sep '25 revenue of ₹ 106.37 crore. This represent the decline of -15.78% The revenue of Solara Active Pharma Sciences Ltd for the Dec '25 is ₹ 349 crore as compare to the Sep '25 revenue of ₹ 314.03 crore. This represent the growth of 11.14% The ebitda of Beta Drugs Ltd for the Dec '25 is ₹ 19.3 crore as compare to the Sep '25 ebitda of ₹ 24.3 crore. This represent the decline of -20.58% The ebitda of Solara Active Pharma Sciences Ltd for the Dec '25 is ₹ 30.59 crore as compare to the Sep '25 ebitda of ₹ 35.22 crore. This represent the decline of -13.15% The net profit of Beta Drugs Ltd changed from ₹ 8.95 crore to ₹ 8.52 crore over 5 quarters. This represents a CAGR of -3.86% The net profit of Solara Active Pharma Sciences Ltd changed from ₹ -13.46 crore to ₹ -17.43 crore over 7 quarters. This represents a CAGR of 15.92% The Dividend Payout of Beta Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Solara Active Pharma Sciences Ltd changed from 11.38 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Beta Drugs Ltd

Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

About Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
These drugs primarily deal with anthelmintic, anti-malarias, beta blockers, muscle relaxants, novel oral anticoagulants, anti-infective and other niche segments.

FAQs for the comparison of Beta Drugs Ltd and Solara Active Pharma Sciences Ltd

Which company has a larger market capitalization, Beta Drugs Ltd or Solara Active Pharma Sciences Ltd?

Market cap of Beta Drugs Ltd is 1,360 Cr while Market cap of Solara Active Pharma Sciences Ltd is 1,906 Cr

What are the key factors driving the stock performance of Beta Drugs Ltd and Solara Active Pharma Sciences Ltd?

The stock performance of Beta Drugs Ltd and Solara Active Pharma Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beta Drugs Ltd and Solara Active Pharma Sciences Ltd?

As of May 12, 2026, the Beta Drugs Ltd stock price is INR ₹1341.8. On the other hand, Solara Active Pharma Sciences Ltd stock price is INR ₹527.15.

How do dividend payouts of Beta Drugs Ltd and Solara Active Pharma Sciences Ltd compare?

To compare the dividend payouts of Beta Drugs Ltd and Solara Active Pharma Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.